James B. Renacci bought Novo Nordisk A/S (NYSE: NVO)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 14 trades in Novo Nordisk A/S (NVO) since 2014, 9 purchases and 5 sales, worth an estimated $277K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $15,001 - $50,000 of Novo Nordisk A/S (NYSE: NVO) on May 25, 2016. Since that trade, NVO is up +130.70% against the S&P 500 up +310.27%, an outperformance of -179.57%.
Across these filings, James B. Renacci has been a net buyer of NVO (a buy-to-sell ratio of 1.80). The most recent disclosed NVO transaction shown was dated September 28, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's NVO trades vs the price
NVO is up +130.70% since James B. Renacci bought on May 25, 2016, versus +310.27% for the S&P 500.
Performance since this trade
All James B. Renacci NVO trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & NVO trading FAQ
Is it legal for James B. Renacci to trade Novo Nordisk A/S (NVO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novo Nordisk A/S (NVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy NVO?
James B. Renacci disclosed a purchase of $15,001 - $50,000 of Novo Nordisk A/S (NVO) on May 25, 2016, according to public STOCK Act filings.
How has NVO performed since James B. Renacci's trade?
Since James B. Renacci bought NVO on May 25, 2016, the stock is up +130.70%, versus +310.27% for the S&P 500 over the same period, an outperformance of -179.57%.
How many times has James B. Renacci traded NVO?
James B. Renacci has disclosed 14 NVO trades since 2014 (9 purchases and 5 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVO trades?
Quantellect tracks every disclosed congressional trade in Novo Nordisk A/S (NVO) on the Novo Nordisk A/S congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's NVO tradesAll congressional filings for Novo Nordisk A/SJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.